B Cell News and Research

RSS

Penn study provides insight into how cells maintain identity during replication

Prior to cell division, chromosomes are seemingly a jumbled mess. During cell division, parent cell chromosomes and their duplicates sort themselves out by condensing, becoming thousands of times more compact than at any other time.

15 Sep 2017

Heidelberg researchers gain new insights into formation of blood vessels

New insights into the development of the vascular system: researchers in the team of Dr Carmen Ruiz de Almodóvar of the Heidelberg University Biochemistry Center have discovered a crucial biological step that regulates the formation of blood vessels.

15 Sep 2017

Study highlights complexity of childhood cancer survivors’ medical needs

Survivors of childhood cancer may experience, on average, nearly twice as many chronic health condition by the age of 45, compared to the general population, according to a new study led by St Jude Children’s Research Hospital (USA) and published in The Lancet.

15 Sep 2017

‘Nanokicking’ technology allows scientists to grow 3D mineralized bone tissue

Researchers from the Universities of Glasgow, Strathclyde, the West of Scotland and Galway have grown three-dimensional samples of mineralized bone from human mesenchymal stem cells for the first time without typical osteoinductive media.

15 Sep 2017

Studies reveal link between autism and severe maternal infection during pregnancy

Two studies conducted at the Massachusetts Institute of Technology (MIT) and the University of Massachusetts Medical School indicated that mothers who were affected with severe infections that required hospitalization are at an increased risk of having an autistic child.

15 Sep 2017

Research highlights problems with titanium based nanoparticles in joint implants

A team of researchers from Mayo Clinic have found that that Titanium Dioxide (TiO2) nanoparticles that are present in bone implants may be causing harm by impairing bone formation and interfering with resorption at the site of repair. This can lead to loosening of the implants and pain.

15 Sep 2017

IUPUI cell biologist receives $1.9 million grant to tackle age-related hearing loss

Cell biologist Benjamin J. Perrin of the School of Science at Indiana University-Purdue University Indianapolis is advancing knowledge of age-related hearing loss with the goal of informing possible therapeutic cell-regeneration approaches to the often-debilitating problem.

14 Sep 2017

BWH researchers identify new rare genetic cause of peritoneal mesothelioma

Mesothelioma is a rare and aggressive tumor that, in many cases, results from exposure to asbestos. But over the last several decades, other causes of the disease have emerged, including treatment with high-intensity therapeutic radiation and, more recently, an inherited genetic mutation.

14 Sep 2017

UF scientists to use $2.7 million NIH grant for preventing influenza viruses in animals and humans

University of Florida researchers will use a $2.7 million National Institutes of Health grant to study whether they can harness an unusual type of immune cell in pigs to treat and prevent influenza viruses in animals and humans.

14 Sep 2017

Boise State professor wins federal grant to explore basic functions of the genome

It's rare for a faculty member in any physics department to earn a federal grant administered by the National Institutes of Health, but that is exactly what Boise State assistant professor and biophysicist Matt Ferguson has done.

14 Sep 2017

Researchers identify natural compound that appears to shut down cancer cells' energy source

The Warburg Effect describes a phenomenon in which cancer cells voraciously consume glucose for energy -- something scientists have long known, yet have had little success exploiting as a way to stunt tumor growth.

14 Sep 2017

FDA grants accelerated approval to new drug for treating relapsed follicular lymphoma

The U.S. Food and Drug Administration today granted accelerated approval to Aliqopa (copanlisib) for the treatment of adults with relapsed follicular lymphoma who have received at least two prior treatments known as systemic therapies.

14 Sep 2017

FDA grants approval for new biosimilar to treat multiple types of cancer

The U.S. Food and Drug Administration today approved Mvasi (bevacizumab-awwb) as a biosimilar to Avastin (bevacizumab) for the treatment of multiple types of cancer. Mvasi is the first biosimilar approved in the U.S. for the treatment of cancer.

14 Sep 2017

MSC transplantation can be safe, effective approach to treat Crohn's disease-related fistula

A growing body of clinical evidence shows that transplantation of a patient's own mesenchymal stem cells (MSCs) to achieve a cure and prevent recurrent of Crohn's disease-related fistula can be a safe and effective addition to surgery.

14 Sep 2017

Leeds Teaching Hospitals to introduce private stem cell collection and storage option for patients

The Leeds Teaching Hospitals NHS Trust is continually striving to provide high quality, patient centred care to each and every patient. Smart Cells International, in association with the trust, will be introducing the option for patients to privately store stem cells from the umbilical cord across St James’s University Hospital, Leeds General Infirmary and Wharfedale Hospital.

14 Sep 2017

New clinical trial begins testing Epigem’s instrument for detection, cure of rare anemias

Epigem today announced that one of its development instruments, MeChem, is being tested in a new clinical trial into the detection and cure of rare anemias. The company has filed two patents relating to the test methods and the associated system.

14 Sep 2017

Modified blood thinner may be first promising method to prevent repercussions after TBI

A chemically modified version of the common blood thinner heparin may be the first promising method of preventing the harmful cascade of destruction to brain tissue that commonly follows traumatic brain injury (TBI), according to new research findings.

13 Sep 2017

Researchers overcome major stumbling blocks in developing HIV vaccine

An international team of researchers has demonstrated a way of overcoming one of the major stumbling blocks that has prevented the development of a vaccine against HIV: the ability to generate immune cells that stay in circulation long enough to respond to and stop virus infection.

13 Sep 2017

Combination immunotherapy shows better overall survival in kidney cancer patients

A combination immunotherapy treatment showed better overall survival in patients with previously untreated advanced or metastatic renal cell carcinoma than current therapy, according to results from a phase 3 clinical trial presented at the Presidential Symposium of the European Society for Medical Oncology's 2017 Congress in Spain.

13 Sep 2017

Arkansas professor makes strides toward developing enhanced cancer treatment

A University of Arkansas at Little Rock professor is making strides toward developing an effective cancer treatment without the severe side effects of traditional therapies.

13 Sep 2017

B Cell News and Research

Penn study provides insight into how cells maintain identity during replication

Heidelberg researchers gain new insights into formation of blood vessels

Study highlights complexity of childhood cancer survivors’ medical needs

‘Nanokicking’ technology allows scientists to grow 3D mineralized bone tissue

Studies reveal link between autism and severe maternal infection during pregnancy

Research highlights problems with titanium based nanoparticles in joint implants

IUPUI cell biologist receives $1.9 million grant to tackle age-related hearing loss

BWH researchers identify new rare genetic cause of peritoneal mesothelioma

UF scientists to use $2.7 million NIH grant for preventing influenza viruses in animals and humans

Boise State professor wins federal grant to explore basic functions of the genome

Researchers identify natural compound that appears to shut down cancer cells' energy source

FDA grants accelerated approval to new drug for treating relapsed follicular lymphoma

FDA grants approval for new biosimilar to treat multiple types of cancer

MSC transplantation can be safe, effective approach to treat Crohn's disease-related fistula

Leeds Teaching Hospitals to introduce private stem cell collection and storage option for patients

New clinical trial begins testing Epigem’s instrument for detection, cure of rare anemias

Modified blood thinner may be first promising method to prevent repercussions after TBI

Researchers overcome major stumbling blocks in developing HIV vaccine

Combination immunotherapy shows better overall survival in kidney cancer patients

Arkansas professor makes strides toward developing enhanced cancer treatment

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News